This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Class IV drugs in atrial fibrillation

Authoring team

Drugs such as verapamil and diltiazem increase the refractory period of the atrioventricular node and so control the ventricular response to atrial fibrillation.

Disadvantages of verapamil include:

  • a lower rate of conversion to sinus rhythm than with class IV or class I drugs
  • a danger of malignant ventricular arrhythmias if there is underlying Wolff-Parkinson-White syndrome
  • a lack of efficacy in paroxysmal atrial fibrillation

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.